	流动资产		日
Acadia Pharmaceuticals	USD 1.22B	128.53M	2026-06
Agios Pharmaceuticals	USD 717.67M	117.18M	2026-06
Alnylam Pharmaceuticals	USD 4.62B	400.86M	2026-06
BioCryst Pharmaceuticals	USD 484.68M	111.06M	2026-06
BioMarin Pharmaceutical	USD 3.97B	633.45M	2026-06
Immunic	USD 188.76M	165.89M	2026-03
Insmed	USD 1.63B	20.75M	2026-06
Ionis Pharmaceuticals	USD 2.49B	446.73M	2026-06
Karyopharm Therapeutics	USD 126.33M	23.19M	2026-03
Kyowa Hakko Kirin	JPY 517.76B	57.88B	2026-06
MacroGenics	USD 321.69M	139.16M	2026-06
Moderna	USD 5.82B	45M	2026-06
Neurocrine Biosciences	USD 1.64B	798.6M	2026-06
PTC Therapeutics	USD 2.62B	363.36M	2026-06
Puma Biotechnology	USD 143.58M	7M	2025-09
Regeneron Pharmaceuticals	USD 18.45B	236.8M	2026-06
Sarepta Therapeutics	USD 2.22B	86.05M	2026-06
Ultragenyx Pharmaceutical	USD 606M	51M	2026-06
Vertex Pharmaceuticals	USD 12.54B	813.4M	2026-06